Company overview
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria preventative treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for Zika, respiratory viruses, and dengue. It also has patent license agreement with Tufts Medical Center to jointly advance the development and commercialization of tafenoquine for the treatment and prevention of babesiosis. The company was founded in 2010 and is headquartered in Washington, District Of Columbia.
Daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-08. TTM means trailing twelve months. Use the market date when comparing SXTP with another company.
| Daily close (USD) | $0.97 |
| Market capitalization (USD) | $3,420,270.83 |
| Price / earnings (TTM) | Not reported |
| Price / book | 1.35 |
No matching rows. Clear the filter to see all records.
Read SXTP's valuation metrics
Company size
60 Degrees Pharmaceuticals, Inc. Common Stock's recorded market capitalization is $3,420,270.83. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
SXTP's recorded price-to-book ratio is 1.35. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research 60 Degrees Pharmaceuticals, Inc. Common Stock with Aurora
Use the snapshot above to ask a specific question about SXTP. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow SXTP's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.